fda warning bpc-157 compounding safety risks Peptide Crackdown: What Pharmacists Need to Know Regulatory Updates on Compounded Peptides
Description
Acta Pharmacol Sin 2002
Medical Conditions Requiring Caution: Individuals with heart conditions Those with liver or kidney disease People with metabolic disorders Patients with Leber's disease (affecting the optic nerve) Those with low potassium levels (hypokalemia) [12] Pregnancy and breastfeeding present special considerations for MIC B12 treatment
Its the subject of ongoing studies
305 , G749G759 (2013)
